Home
ALNY
ALNY News

Latest Alnylam Pharmaceuticals Inc. (ALNY) News on October 9, 2025

Discover 3 Stocks Including ConnectOne Bancorp Priced Below Estimated Value

Simply Wall St.

2 days ago

Discover 3 Stocks Including ConnectOne Bancorp Priced Below Estimated Value

Discovering Bank First And 2 More Stocks That May Be Trading Below Their Estimated Value

Simply Wall St.

2 days ago

Discovering Bank First And 2 More Stocks That May Be Trading Below Their Estimated Value

3 Stocks Estimated To Be Trading At Discounts Of Up To 42.8%

Simply Wall St.

3 days ago

3 Stocks Estimated To Be Trading At Discounts Of Up To 42.8%

MT Newswires

3 days ago

Morgan Stanley Raises Price Target on Alnylam Pharmaceuticals to $475 From $405, Keeps Equalweight Rating

Argus Research

3 days ago

Daily – Vickers Top Buyers & Sellers for 10/06/2025

Loss-Making Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Set To Breakeven

Simply Wall St.

5 days ago

Loss-Making Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Set To Breakeven

MT Newswires

5 days ago

Alnylam Pharmaceuticals Insider Sold Shares Worth $2,692,062, According to a Recent SEC Filing

MT Newswires

5 days ago

Alnylam Pharmaceuticals Insider Sold Shares Worth $1,103,451, According to a Recent SEC Filing

MT Newswires

5 days ago

Alnylam Pharmaceuticals Insider Sold Shares Worth $635,126, According to a Recent SEC Filing

MT Newswires

5 days ago

Alnylam Pharmaceuticals Insider Sold Shares Worth $4,034,085, According to a Recent SEC Filing

Discovering GeneDx Holdings And Two Stocks Possibly Priced Below Estimated Value

Simply Wall St.

5 days ago

Discovering GeneDx Holdings And Two Stocks Possibly Priced Below Estimated Value

3 Stocks That May Be Trading Below Estimated Value In October 2025

Simply Wall St.

6 days ago

3 Stocks That May Be Trading Below Estimated Value In October 2025

Alnylam (ALNY) Reports 238% Growth in Amvuttra Since February Launch, RBC Raises Price Target

Insider Monkey

6 days ago

Alnylam (ALNY) Reports 238% Growth in Amvuttra Since February Launch, RBC Raises Price Target

3 Stocks Estimated To Be Trading At Discounts Up To 44.4%

Simply Wall St.

6 days ago

3 Stocks Estimated To Be Trading At Discounts Up To 44.4%

Wealth Enhancement Slashes Alnylam Pharmaceuticals, Inc. (ALNY) Stake by 64.5%

Insider Monkey

7 days ago

Wealth Enhancement Slashes Alnylam Pharmaceuticals, Inc. (ALNY) Stake by 64.5%

3 Stocks That May Be Undervalued By 20.3% To 41.4%

Simply Wall St.

7 days ago

3 Stocks That May Be Undervalued By 20.3% To 41.4%

3 Stocks That May Be Trading Below Estimated Fair Value

Simply Wall St.

7 days ago

3 Stocks That May Be Trading Below Estimated Fair Value

Can Alnylam's Broader Portfolio Ease Its Dependence on Amvuttra?

Zacks

8 days ago

Can Alnylam's Broader Portfolio Ease Its Dependence on Amvuttra?

3 Stocks Estimated To Be Up To 42.7% Below Intrinsic Value

Simply Wall St.

8 days ago

3 Stocks Estimated To Be Up To 42.7% Below Intrinsic Value

Alnylam Announces First Patient Dosed in ZENITH Global Phase 3 Cardiovascular Outcomes Trial of Zilebesiran

Business Wire

8 days ago

Alnylam Announces First Patient Dosed in ZENITH Global Phase 3 Cardiovascular Outcomes Trial of Zilebesiran

Alnylam’s AMVUTTRA Reduces GI Events in ATTR-CM Patients, According to New HELIOS-B Data

Insider Monkey

8 days ago

Alnylam’s AMVUTTRA Reduces GI Events in ATTR-CM Patients, According to New HELIOS-B Data

Alnylam Pharmaceuticals, Inc. (ALNY) Reports $492M Amvuttra Sales, Raises 2025 Revenue Guidance

Insider Monkey

8 days ago

Alnylam Pharmaceuticals, Inc. (ALNY) Reports $492M Amvuttra Sales, Raises 2025 Revenue Guidance

New Data from HELIOS-B Phase 3 Study Demonstrate Lower Rates of Gastrointestinal Events in ATTR-CM Patients Treated with Vutrisiran

Business Wire

9 days ago

New Data from HELIOS-B Phase 3 Study Demonstrate Lower Rates of Gastrointestinal Events in ATTR-CM Patients Treated with Vutrisiran

Is Alnylam Pharmaceuticals (NASDAQ:ALNY) Using Debt In A Risky Way?

Simply Wall St.

10 days ago

Is Alnylam Pharmaceuticals (NASDAQ:ALNY) Using Debt In A Risky Way?

Cyberattack hits Asahi’s Japan business

Just Drinks

10 days ago

Cyberattack hits Asahi’s Japan business

New Zealand wine exports up “subdued” 5%

Just Drinks

10 days ago

New Zealand wine exports up “subdued” 5%

MT Newswires

10 days ago

Algoma Steel Secures $359 Million Liquidity Support From Canadian Government

The Riksbank's deposit requirement and the effect on the volume of Riksbank certificates offered

GlobeNewswire

10 days ago

The Riksbank's deposit requirement and the effect on the volume of Riksbank certificates offered

Digital Asset Funds Log $812M Outflows, Solana Draws $291M Inflows: CoinShares

Cryptonews

10 days ago

Digital Asset Funds Log $812M Outflows, Solana Draws $291M Inflows: CoinShares

MT Newswires

10 days ago

Commerzbank Sees Australia's Central Bank on Hold This Week

MT Newswires

10 days ago

Amber International to Help Advance Web3 Initiatives of Gaming Operator CMGE

Innovating Internal Communications Seminar: Navigating Uncertainty and Drive Change - Strategies To Lead Through Disruption (Nashville, Tennessee, United States - September 30, 2025 and Oct 2, 2025)

GlobeNewswire

10 days ago

Innovating Internal Communications Seminar: Navigating Uncertainty and Drive Change - Strategies To Lead Through Disruption (Nashville, Tennessee, United States - September 30, 2025 and Oct 2, 2025)

MT Newswires

10 days ago

Alnylam Pharmaceuticals Says Amvuttra Reduces Gastrointestinal Events in Study

Is Alnylam Pharmaceuticals (ALNY) an Undervalued Stock?

Insider Monkey

14 days ago

Is Alnylam Pharmaceuticals (ALNY) an Undervalued Stock?

Does Alnylam Pharmaceuticals (ALNY) Have the Potential to Generate Strong Long-Term Growth?

Insider Monkey

14 days ago

Does Alnylam Pharmaceuticals (ALNY) Have the Potential to Generate Strong Long-Term Growth?

September 2025's Top Stocks Estimated To Be Trading Below Fair Value

Simply Wall St.

14 days ago

September 2025's Top Stocks Estimated To Be Trading Below Fair Value

Why Alnylam Pharmaceuticals (ALNY) is a Top Momentum Stock for the Long-Term

Zacks

15 days ago

Why Alnylam Pharmaceuticals (ALNY) is a Top Momentum Stock for the Long-Term

With DTC ads under fire, pharma companies need to pivot

Pharma Voice

17 days ago

With DTC ads under fire, pharma companies need to pivot

Does Alnylam's Entry Into the Genomics Alliance Hint at a New Era for Illumina (ILMN) R&D?

Simply Wall St.

19 days ago

Does Alnylam's Entry Into the Genomics Alliance Hint at a New Era for Illumina (ILMN) R&D?

MT Newswires

20 days ago

RBC Raises Price Target on Alnylam Pharmaceuticals to $500 From $435, Keeps Outperform Rating

MT Newswires

21 days ago

Alnylam Joins Alliance for Genomic Discovery

Alnylam Pharmaceuticals Insiders Sold US$12m Of Shares Suggesting Hesitancy

Simply Wall St.

21 days ago

Alnylam Pharmaceuticals Insiders Sold US$12m Of Shares Suggesting Hesitancy

Alnylam Pharmaceuticals joins Alliance for Genomic Discovery, expanding diverse clinical genomic dataset to drive precision medicine

PR Newswire

21 days ago

Alnylam Pharmaceuticals joins Alliance for Genomic Discovery, expanding diverse clinical genomic dataset to drive precision medicine

Corner Therapeutics Appoints Biotech Pioneer John Maraganore as Strategic Adviser

Business Wire

21 days ago

Corner Therapeutics Appoints Biotech Pioneer John Maraganore as Strategic Adviser

Will Positive HELIOS-B Data and $575 Million Offering Transform Alnylam’s (ALNY) RNAi Therapy Narrative?

Simply Wall St.

a month ago

Will Positive HELIOS-B Data and $575 Million Offering Transform Alnylam’s (ALNY) RNAi Therapy Narrative?

Top 20 biopharma market caps fall 5.7% amid industry challenges

Pharmaceutical Technology

a month ago

Top 20 biopharma market caps fall 5.7% amid industry challenges

Alnylam (ALNY) Surges 6.0%: Is This an Indication of Further Gains?

Zacks

a month ago

Alnylam (ALNY) Surges 6.0%: Is This an Indication of Further Gains?

MT Newswires

a month ago

Alnylam Pharmaceuticals Prices Upsized $575 Million Convertible Senior Notes Offering

Alnylam Announces Pricing of Upsized Offering of $575 Million Convertible Senior Notes

Business Wire

a month ago

Alnylam Announces Pricing of Upsized Offering of $575 Million Convertible Senior Notes

MT Newswires

a month ago

Alnylam Launches $500 Million Convertible Notes Offering

Alnylam Announces Proposed Offering of $500 Million Convertible Senior Notes

Business Wire

a month ago

Alnylam Announces Proposed Offering of $500 Million Convertible Senior Notes

Can ALNY's Key Partnerships With Pharma Giants Drive Long-Term Growth?

Zacks

a month ago

Can ALNY's Key Partnerships With Pharma Giants Drive Long-Term Growth?

Are Options Traders Betting on a Big Move in Alnylam Pharmaceuticals Stock?

Zacks

a month ago

Are Options Traders Betting on a Big Move in Alnylam Pharmaceuticals Stock?

RNAi Technology Market Size to Reach USD 6.63 Billion with 10.4% CAGR by 2033, Report by DataM Intelligence

PR Newswire

a month ago

RNAi Technology Market Size to Reach USD 6.63 Billion with 10.4% CAGR by 2033, Report by DataM Intelligence

MT Newswires

a month ago

Alnylam Pharmaceuticals Insider Sold Shares Worth $1,557,649, According to a Recent SEC Filing

Should You Add Alnylam Pharmaceuticals (ALNY) to Your Portfolio?

Insider Monkey

a month ago

Should You Add Alnylam Pharmaceuticals (ALNY) to Your Portfolio?

Hemab Therapeutics Expands Leadership with Appointment of Anant Murthy, PhD, as Chief Operating Officer

PR Newswire

a month ago

Hemab Therapeutics Expands Leadership with Appointment of Anant Murthy, PhD, as Chief Operating Officer

Alnylam reports new analysis from trial of Amvuttra for ATTR-CM

Clinical Trials Arena

a month ago

Alnylam reports new analysis from trial of Amvuttra for ATTR-CM

Startup Corsera Health aims to bring preventive heart medicine to the masses

BioPharma Dive

a month ago

Startup Corsera Health aims to bring preventive heart medicine to the masses

ALNY/RHHBY's Zilebesiran to Enter Phase III After Third Phase II Win

Zacks

a month ago

ALNY/RHHBY's Zilebesiran to Enter Phase III After Third Phase II Win

Analysts Are Optimistic We'll See A Profit From Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)

Simply Wall St.

a month ago

Analysts Are Optimistic We'll See A Profit From Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)

Large-cap biotech is a sector to watch for investors: Analysts

Yahoo Finance

a month ago

Large-cap biotech is a sector to watch for investors: Analysts

New Data From Landmark HELIOS-B Phase 3 Study Presented at ESC Congress 2025 Demonstrate Vutrisiran’s Long-Term Cardiovascular Benefit in ATTR-CM

Business Wire

a month ago

New Data From Landmark HELIOS-B Phase 3 Study Presented at ESC Congress 2025 Demonstrate Vutrisiran’s Long-Term Cardiovascular Benefit in ATTR-CM

Roche and Alnylam advance zilebesiran into global phase III cardiovascular outcomes trial for people with uncontrolled hypertension

GlobeNewswire

a month ago

Roche and Alnylam advance zilebesiran into global phase III cardiovascular outcomes trial for people with uncontrolled hypertension

Alnylam to Advance Zilebesiran into Global Phase 3 Cardiovascular Outcomes Trial

Business Wire

a month ago

Alnylam to Advance Zilebesiran into Global Phase 3 Cardiovascular Outcomes Trial

Genentech and Alnylam Advance Zilebesiran Into Global Phase III Cardiovascular Outcomes Trial for People With Uncontrolled Hypertension

Business Wire

a month ago

Genentech and Alnylam Advance Zilebesiran Into Global Phase III Cardiovascular Outcomes Trial for People With Uncontrolled Hypertension

Can Alnylam Rely on Amvuttra to Sustain Its Rapid Sales Momentum?

Zacks

a month ago

Can Alnylam Rely on Amvuttra to Sustain Its Rapid Sales Momentum?

Next Generation Drug Conjugates Market Report 2025-2035, with Profiles of Advanced Accelerator Applications, Alnylam Pharmaceuticals, Arrowhead, Dicerna Pharmaceuticals, Geron, & Ionis Pharmaceuticals

GlobeNewswire

a month ago

Next Generation Drug Conjugates Market Report 2025-2035, with Profiles of Advanced Accelerator Applications, Alnylam Pharmaceuticals, Arrowhead, Dicerna Pharmaceuticals, Geron, & Ionis Pharmaceuticals

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

Zacks

a month ago

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

Alnylam to Webcast Presentations at Upcoming September Investor Conferences

Business Wire

a month ago

Alnylam to Webcast Presentations at Upcoming September Investor Conferences

Calculating The Fair Value Of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)

Simply Wall St.

a month ago

Calculating The Fair Value Of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)

Scenic Enters License and Research Agreement with Alnylam

GlobeNewswire

a month ago

Scenic Enters License and Research Agreement with Alnylam

Leaders Come Together to Advance the Industry at Veeva Summit

PR Newswire

2 months ago

Leaders Come Together to Advance the Industry at Veeva Summit

MT Newswires

2 months ago

Alnylam Pharmaceuticals Insider Sold Shares Worth $632,759, According to a Recent SEC Filing

MT Newswires

2 months ago

Alnylam Pharmaceuticals Insider Sold Shares Worth $3,163,346, According to a Recent SEC Filing

MT Newswires

2 months ago

Alnylam Pharmaceuticals Insider Sold Shares Worth $1,030,727, According to a Recent SEC Filing

MT Newswires

2 months ago

Alnylam Pharmaceuticals Insider Sold Shares Worth $1,299,746, According to a Recent SEC Filing

Three Companies That Might Be Priced Below Their Estimated Value

Simply Wall St.

2 months ago

Three Companies That Might Be Priced Below Their Estimated Value

Is Alnylam Pharmaceuticals (NASDAQ:ALNY) Using Too Much Debt?

Simply Wall St.

2 months ago

Is Alnylam Pharmaceuticals (NASDAQ:ALNY) Using Too Much Debt?

Private Credit Is a Booming Business. Where One Pro Sees Risks and Opportunities Now.

Barrons.com

2 months ago

Private Credit Is a Booming Business. Where One Pro Sees Risks and Opportunities Now.

Profits May Be Just Around the Corner for This Strong-Buy Pharma Stock

Barchart

2 months ago

Profits May Be Just Around the Corner for This Strong-Buy Pharma Stock

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

Zacks

2 months ago

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

Possible Bearish Signals With Alnylam Pharmaceuticals Insiders Disposing Stock

Simply Wall St.

2 months ago

Possible Bearish Signals With Alnylam Pharmaceuticals Insiders Disposing Stock

Alnylam to Present Progress in Transforming the Treatment of Cardiovascular Disease with RNAi Therapeutics at European Society of Cardiology Congress 2025

Business Wire

2 months ago

Alnylam to Present Progress in Transforming the Treatment of Cardiovascular Disease with RNAi Therapeutics at European Society of Cardiology Congress 2025

Exploring Three High Growth Tech Stocks In The US Market

Simply Wall St.

3 months ago

Exploring Three High Growth Tech Stocks In The US Market

Exploring 3 High Growth Tech Stocks in the US Market

Simply Wall St.

3 months ago

Exploring 3 High Growth Tech Stocks in the US Market

Exploring High Growth Tech Stocks In The US Market

Simply Wall St.

3 months ago

Exploring High Growth Tech Stocks In The US Market

When Will Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Become Profitable?

Simply Wall St.

3 months ago

When Will Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Become Profitable?

Exploring Three High Growth Tech Stocks in the US Market

Simply Wall St.

3 months ago

Exploring Three High Growth Tech Stocks in the US Market

Exploring US High Growth Tech Stocks For Potential Opportunities

Simply Wall St.

3 months ago

Exploring US High Growth Tech Stocks For Potential Opportunities

US High Growth Tech Stocks To Watch In June 2025

Simply Wall St.

3 months ago

US High Growth Tech Stocks To Watch In June 2025

High Growth Tech Stocks To Watch In US June 2025

Simply Wall St.

3 months ago

High Growth Tech Stocks To Watch In US June 2025

Exploring US High Growth Tech Stocks To Watch In June 2025

Simply Wall St.

3 months ago

Exploring US High Growth Tech Stocks To Watch In June 2025

Exploring 3 High Growth Tech Stocks In The US Market

Simply Wall St.

4 months ago

Exploring 3 High Growth Tech Stocks In The US Market

High Growth Tech Stocks in US for June 2025

Simply Wall St.

4 months ago

High Growth Tech Stocks in US for June 2025

Exploring 3 High Growth Tech Stocks in the US Market

Simply Wall St.

4 months ago

Exploring 3 High Growth Tech Stocks in the US Market

Exploring Three High Growth Tech Stocks In The US Market

Simply Wall St.

4 months ago

Exploring Three High Growth Tech Stocks In The US Market

Alnylam Pharmaceuticals (NasdaqGS:ALNY) Appoints New R&D Chief to Drive Growth Phase

Simply Wall St.

4 months ago

Alnylam Pharmaceuticals (NasdaqGS:ALNY) Appoints New R&D Chief to Drive Growth Phase

Alnylam names Pushkal Garg as EVP, chief research and development officer

TipRanks

4 months ago

Alnylam names Pushkal Garg as EVP, chief research and development officer

Alnylam Announces Promotion of Pushkal Garg to Chief Research and Development Officer

Business Wire

4 months ago

Alnylam Announces Promotion of Pushkal Garg to Chief Research and Development Officer

Share on Social Networks: